CLINICAL_TRIALS
trial_result
· 2022-09-21
Clinical Trial Update: Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease. [Phase 3]
Summary
A Phase 3 trial comparing Vedolizumab IV to placebo in Chinese participants with Crohn's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-09-21